Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bisoxatin Diacetate
1. 14008-48-1
2. Wy 8138
3. Wy-8138
4. 79w5lfs83k
5. Laxonalin
6. Maratan
7. 2,2-bis(p-hydroxyphenyl)-2h-1,4-benzoxazin-3(4h)-one Diacetate
8. 2h-1,4-benzoxazin-3(4h)-one, 2,2-bis(4-(acetyloxy)phenyl)-
9. Ncgc00182998-01
10. Metrolax
11. Wylaxine
12. Talsis
13. Tasis
14. Kritel Tropfen
15. (3-oxo-3,4-dihydro-2h-benzo[b][1,4]oxazine-2,2-diyl)bis(4,1-phenylene) Diacetate
16. Bisoxatin Acetate [usan:jan]
17. Einecs 237-820-5
18. Brn 0589169
19. Unii-79w5lfs83k
20. 2,2-bis(4-acetoxyphenyl)-2h-1,4-benzoxazin-3(4h)-one
21. 2,2-bis(4-acetoxyphenyl)-3-oxo-2,3-dihydrobenz-1,4-oxazine
22. 2h-1,4-benzoazin-3(4h)-one, 2,2-bis(4-(acetoxy)phenyl)-
23. 2,2-bis(p-hydroxyphenyl)-2h-1,4-benzoazin-3(4h)-one Diacetate
24. 2,2-bis(4-(acetyloxy)phenyl)-2h-1,4-benzoxazin-3(4h)-one Diacetate
25. [4-[2-(4-acetyloxyphenyl)-3-oxo-4h-1,4-benzoxazin-2-yl]phenyl] Acetate
26. Dsstox_cid_28765
27. Dsstox_rid_83034
28. Dsstox_gsid_48839
29. Schembl364629
30. Bisoxatin Acetate [mi]
31. Bisoxatin Acetate (jan/usan)
32. Bisoxatin Acetate [jan]
33. Bisoxatin Acetate [usan]
34. Chembl2106004
35. Dtxsid1048839
36. Chebi:31294
37. Bisoxatin Acetate [mart.]
38. Zinc608211
39. Bisoxatin Acetate [who-dd]
40. Bcp31468
41. Tox21_113321
42. 2h-1,4-benzoxazin-3-(4h)-one, 2,2-bis(p-hydroxyphenyl)-, Diacetate
43. Db14654
44. Cas-14008-48-1
45. Ft-0724909
46. D01191
47. Q27266785
48. 4,4'-(3-oxo-3,4-dihydro-2h-benzo[b][1,4]oxazine-2,2-diyl)bis(4,1-phenylene) Diacetate
| Molecular Weight | 417.4 g/mol |
|---|---|
| Molecular Formula | C24H19NO6 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 417.12123733 g/mol |
| Monoisotopic Mass | 417.12123733 g/mol |
| Topological Polar Surface Area | 90.9 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 642 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
19
PharmaCompass offers a list of Bisoxatin acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisoxatin acetate manufacturer or Bisoxatin acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisoxatin acetate manufacturer or Bisoxatin acetate supplier.
PharmaCompass also assists you with knowing the Bisoxatin acetate API Price utilized in the formulation of products. Bisoxatin acetate API Price is not always fixed or binding as the Bisoxatin acetate Price is obtained through a variety of data sources. The Bisoxatin acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metrolax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metrolax, including repackagers and relabelers. The FDA regulates Metrolax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metrolax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metrolax supplier is an individual or a company that provides Metrolax active pharmaceutical ingredient (API) or Metrolax finished formulations upon request. The Metrolax suppliers may include Metrolax API manufacturers, exporters, distributors and traders.
click here to find a list of Metrolax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metrolax written confirmation (Metrolax WC) is an official document issued by a regulatory agency to a Metrolax manufacturer, verifying that the manufacturing facility of a Metrolax active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metrolax APIs or Metrolax finished pharmaceutical products to another nation, regulatory agencies frequently require a Metrolax WC (written confirmation) as part of the regulatory process.
click here to find a list of Metrolax suppliers with Written Confirmation (WC) on PharmaCompass.
Metrolax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metrolax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metrolax GMP manufacturer or Metrolax GMP API supplier for your needs.
A Metrolax CoA (Certificate of Analysis) is a formal document that attests to Metrolax's compliance with Metrolax specifications and serves as a tool for batch-level quality control.
Metrolax CoA mostly includes findings from lab analyses of a specific batch. For each Metrolax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metrolax may be tested according to a variety of international standards, such as European Pharmacopoeia (Metrolax EP), Metrolax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metrolax USP).
